Early loss of naive CD8+ T cells found in male mice — News-Medical
UA.NEWS9 Oct · 23:44← Topics · 9 Oct
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Wiley & Sons9 Oct · 23:14
As it stood that day
New studies are tracking T-cell activation and using HER2DX scores to predict breast-cancer treatment response.
84 reports · 9 Oct
Summary · from headlines6 points
- Targeting individual metastases does not improve survival in oligometastatic breast cancer, a randomized trial finds.
- Combination therapy overcomes immunotherapy resistance in glioblastoma in a preclinical study.
- A report finds more men are living longer with incurable prostate cancer.
- Novel radiotherapy may save increasingly many rectal cancer patients from surgery and a stoma.
- NIH backs a $13.1 million effort to attack breast cancer with engineered Salmonella.
- Hormone receptor status and HER2DX score may predict response to lighter HER2+ breast cancer chemo.
Latest developments6 to read first
Immune Cell Map Uncovers How Individual Aging Trajectories Diverge | Newswise
Newswise9 Oct · 23:34Scientists have identified a 'protein signature' in blood that could predict healthy aging
Live Science9 Oct · 23:24Tumor Traits May Predict Who Responds to Lighter HER2+ Breast Cancer Chemo
Cure Today9 Oct · 23:14Hormone Receptor Status, HER2DX Score Predict Response to Neoadjuvant THP
Targeted Oncology9 Oct · 23:14Timeline 84 reports
9 Oct 202684 reports
23:007 reports
22:002 reports
21:005 reports
20:001 report
19:0010 reports
18:006 reports
17:001 report
16:001 report
15:00nothing heard
14:00nothing heard
13:002 reports
12:001 report
11:006 reports
10:003 reports
09:001 report
08:00nothing heard
07:009 reports
06:005 reports
05:001 report
04:001 report
03:008 reports
02:009 reports
01:004 reports
00:001 report
← Topics · 9 OctOne topic